 price
compani updat chang price
accru solid start
thesi updat cardin put best quarter three
distributor beat top pharma bottom line
medic om lower interest/tax big news howev
compani decis take bn opioid accrual
market cap conserv account
treatment distributor help focu
investor attent toward busi fundament
result improv view manag decis
rais guidanc prudent given linger presenc
macro headwind manag work off-set
via restructur etc given set rais
estim price target account improv outlook
view valuat fair reiter in-lin rate
continu confer call note
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
declin gm due pharma distro product renew product mix
time affect point time cash flow affect yoy revers
opioid litig expens report pharma segment
improv market genericsyet sourc volum sell side price
impact
progress gener
continu monitor extern factor time evolut intern
tariff medic devic tax hw
close monitor brand inflat gener program
direct op earn modestli lower
accru tax first quarter serv basi term move
compon year
consider assess capit deploy limit
global settlement accrual repres global framework state
polit subdivis third group privat lawsuit
tax deduct detail specif agreement yet
complet clariti tax code avail yet
flow cash final someth need
set appropri reserv becom clear time
impact credit rate relationship rate agenc invest
grade credit rate import
commit deliv least de-lever year
overal leverag number go
charg charg recogn expens charg
recogn time
pharma enhanc distro busi growth key area
distro businessimprov price contract disciplin reduc
implement digit tech visibl price capabl
specialti multi million invest new distro center new tech
invest higher margin connect care offeringbuild connect
player
compon compens sale incent also around best
practic sell custom
complet materi
suppli chain reconfigur network north america
patient recoveri acquisitionwithin next final plan reduc
cost take time execut
cardin health home solutionsredeploy cost save
digit data capabl streamlin workflow
exceed primarili sg activ
initi improv gross margin like medic right size
manufactur distribut footprint contribut significantli
five year million save goal ramp next
year
creat data analyt fp hub fema hub central
current fema data analyt employe
transit next week alongsid team process
financ data analyt expert
commit pay debt matur
color oper profit
factor impact sg spend larg inventori invest
opportun ramp contract renew contract
renew second custom experienc difficulti
contribut lower volum
oper cash flow full year
fundament structur differ last year work
devic tax built guidanc
devic tax complet clariti annual basi could
neighborhood annual basisbas lack perfect
clariti inform
tariff dynam time work sourc suppli chain initi
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
articl articl
time dissemin novemb
analyst elizabeth anderson suzi yoon primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer part
research analyst compens directli relat specif recommend view research report
